Tag Archives: longacting

Amidst stalled HIV prevention, WHO supports new long-acting prevention drug cabotegravir

New World Health Organization (WHO) guidelines advise countries to use the new potentially game-changing drug which is not yet available for sale, as a pre-exposure prophylaxis (PrEP) for HIV, and as part of a comprehensive approach to prevent the virus from spreading. Those using most PrEP medications on the market, have …

Read More »